Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
For stroke patients, late administration of tenecteplase improved clinical outcomes in situations in which thrombectomy was not available immediately, according to the Chinese TRACE-III trial.
Adding an SGLT2 inhibitor to standard care did not improve clinical outcomes in critically ill patients with acute organ dysfunction, an open-label randomized trial involving
Leaders in diversity, equity, and inclusion (DEI) at academic health centers reported several core challenges in their roles that have led to burnout and isolation,
In the wake of the Supreme Court’s decision to preserve access to mifepristone (Mifeprex) on Thursday, abortion-rights groups worry the threat has not passed while
Medetomidine, an animal tranquilizer more potent than xylazine, recently appeared in drug overdoses in several states in combination with the synthetic opioid fentanyl, sparking concern
Postchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year disease-free survival (DFS) in high-risk diffuse large B-cell lymphoma (DLBCL), a prospective nonrandomized trial
Heating raw milk spiked with H5N1 to temperatures commonly used in commercial pasteurization resulted in a decrease in infectious virus within seconds to minutes, according
VIENNA — Improved drugs to force uric acid excretion as a means of treating gout are inching closer to clinical availability in the U.S., with